Abstract
Introduction. Expression of adhesion molecules such as α v β 3 integrin has been associated with the metastatic potential of tumor cells. The purpose of this study was to determine whether α v β 3 expression correlated with the metastatic potential of human osteosarcoma cells. Materials and methods. We developed a series of sublines (LM2–LM7) from human osteosarcoma SAOS parental cells, with progressively increasing potential to form lung metastases in nude mice after intravenous injection. SAOS parental and LM2 cells were poorly metastatic, but LM7 cells resulted in visible metastatic lung nodules by 6–8 weeks. We quantified α v β 3 integrin expression using flow cytometry. Results. α v β 3 expression correlated with the metastatic potential of the cells, with LM7 cells showing the highest expression. LM7 cell adhesion to vitronectin decreased after treatment with echistatin, a RGD-containing peptide antagonist of α v β 3. LM7 cells demonstrated higher chemotactic activity than SAOS cells to a homogenate made from lung tissue. This chemotactic activity was also inhibited by echistatin. These data indicated that α v β 3 was critical for the migration of LM7 cells to the lung homogenate. Chemotaxis to a liver homogenate was the same for LM7 and SAOS cells. Migration of LM7 cells through lung endothelial cells was higher than that through liver endothelial cells, and echistatin again inhibited this migration. Conclusions. α v β 3 integrin expression may play a role in the metastatic potential of osteosarcoma cells by enhancing the ability of the cells to migrate specifically to the lung. α v β 3 integrin may therefore be a potential new target for osteosarcoma.
Similar content being viewed by others
Abbreviations
- BSA:
-
bovine serum albumin
- EC:
-
endothelial cell
- FBS:
-
fetal bovine serum
- OS:
-
osteosarcoma
- PBS:
-
phosphate-buffered saline
- VN:
-
vitronectin
References
Link MP, Goorin AM, Miser AW et al. The effect of adjuvant therapy on relapse-free survival in patients with osteosarcoma of the extremity. N Engl J Med 1986; 1600–6
B Felding-Habermann E Fransvea TE O’Toole et al. (2002) ArticleTitleInvolvement of tumor cell integrin α v β3 in hematogenous metastasis of human melanoma cells Clinical & Experimental Metastasis 19 427–36
RO. Hynes (1992) ArticleTitleIntegrins: Versatility, modulation, and signaling in cell adhesion Clinical & Experimental Metastasis 69 11–25
L Scheibler DF Mierke G Bitan et al. (2001) ArticleTitleIdentification of a contact domain between echistatin and the integrin α v β3 by photoaffinity cross-linking Clinical & Experimental Metastasis 40 15117–26
B Felding-Habermann TE O’Toole JW Smith et al. (2001) ArticleTitleIntegrin activation controls metastasis in human breast cancer Clinical & Experimental Metastasis 98 1853–8
TG Hullinger LK McCauley ML Dejoode et al. (1998) ArticleTitleEffect of bone marrow endothelial cell line Clinical & Experimental Metastasis 36 14–22
M Platten W Wick C Wild-Bode et al. (2000) ArticleTitleTransforming growth factors β1 (TGF-β1) and TGF-β2 promote glioma cell migration via up-regulation of α v β3 integrin expression Clinical & Experimental Metastasis 268 607–11
N Reinmuth W Liu SA Ahmak et al. (2003) ArticleTitle α v β 3 Integrin antagonist S247 decreases colon cancer metastasis and angiogenesis and improves survival in mice Clinical & Experimental Metastasis 63 2079–87
A Vonlaufen G Wiedle B Borisch et al. (2001) ArticleTitleIntegrin α v β3 expression in colon carcinoma correlates with survival Clinical & Experimental Metastasis 14 IssueID11 1126–32
SF Jia LL Worth ES. Kleinerman (1999) ArticleTitleA nude mouse model of human osteosarcoma lung metastases for evaluating new therapeutic strategies Clinical & Experimental Metastasis 17 501–6
RR Langley KM Ramirez RZ Tsan et al. (2003) ArticleTitleTissue-specific microvascular endothelial cell lines from H-2Kb-tsA58 mice for studies of angiogenesis and metastasis Clinical & Experimental Metastasis 63 2971–6
K Minamiguchi H Kumagai T Masuda et al. (2001) ArticleTitleThiolutin, an inhibitor of HUVEC adhesion to vitronectin, reduces paxillin in HUVECs and suppresses tumor cell-induced angiogenesis Clinical & Experimental Metastasis 93 307–16
R Faccio M Grano S Colucci et al. (2002) ArticleTitleLocalization and possible role of two different alpha v beta 3 integrin conformations in resting and resorbing osteoclasts Clinical & Experimental Metastasis 115 2919–29
EB Voura RA Ramjeesingh AMP Montgomery et al. (2001) ArticleTitleInvolvement of integrin α v β 3 and cell adhesion molecule L1 in transendothelial migration of melanoma cells Clinical & Experimental Metastasis 12 2699–710
EI Deryugina MA Bourdon K Jungwirth et al. (2000) ArticleTitleFunctional activation of integrin α v β3 in tumor cells expressing membrane-type 1 matrix metalloproteinase Clinical & Experimental Metastasis 86 15–23
W Stetler-Stevenson S Aznavoorian L. Liotta (1993) ArticleTitleTumor cell interactions with the extracellular matrix during invasion and metastasis Clinical & Experimental Metastasis 9 541–73
FW Orr HH Wang RM Lafrenie et al. (2000) ArticleTitleInteractions between cancer cells and the endothelium in metastasis Clinical & Experimental Metastasis 190 310–29
IR Hart M Birch JF. Marshall (1991) ArticleTitleCell adhesion receptor expression during melanoma progression and metastasis Clinical & Experimental Metastasis 10 115–28
IJ. Fidler (2001) ArticleTitleSeed and soil revisited Clinical & Experimental Metastasis 10 257–69
S Curran GI. Murray (1999) ArticleTitleMatrix metalloproteinases in tumor invasion and metastasis Clinical & Experimental Metastasis 189 300–8
CC Kumar M Malkowski Z Yin et al. (2001) ArticleTitleInhibition of angiogenesis and tumor growth by SCH221153, a dual α v β2 and α v β5 integrin receptor antagonist Clinical & Experimental Metastasis 61 2232–8
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Duan, X., Jia, SF., Zhou, Z. et al. Association of α v β 3 integrin expression with the metastatic potential and migratory and chemotactic ability of human osteosarcoma cells. Clin Exp Metastasis 21, 747–753 (2005). https://doi.org/10.1007/s10585-005-0599-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10585-005-0599-6